Leuprolide acetate in the management of cesarean scar endometriosis

M E Rivlin, Rivlin Me, S K Das, R B Patel, G R Meeks
Obstetrics and gynecology · 1995 · vol. 85(5) , pp. 838–839 · doi:10.1016/0029-7844(94)00270-n · PMID:7724131 · W2067030982
article OA: closed CC0 ⤵ 62 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Leuprolide acetate treatment for cesarean scar endometriosis improved patient symptoms but did not alter lesion size based on physical examination and CT scans.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Progestin or estrogen-progestin combination therapy has not proven useful in the treatment of endometriosis of the abdominal scar after cesarean delivery. We report our experience in managing this condition with a gonadotropin agonist. CASE: A 22-year-old black woman with a history of two previous cesareans developed endometriosis of the abdominal scar. The extent of the lesion was estimated by computed tomographic (CT) scan, and a 6-month preoperative course of leuprolide acetate was administered. The patient exhibited prompt symptomatic response to the gonadotropin agonist, but the physical examination and CT scan findings were unchanged. Pathologic examination after surgical removal of the lesion confirmed the clinical diagnosis. CONCLUSION: Leuprolide acetate administered to a patient with cesarean scar endometriosis was associated with an improvement in symptoms, but there was no change in lesion size.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Postoperative Complications Adult Cesarean Section Cesarean Section Cicatrix Cicatrix Endometriosis Endometriosis Endometriosis Female Humans Leuprolide Postoperative Complications Pregnancy Tomography, X-Ray Computed

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (3)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:13.665691+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK